ICANN

ICANN

In a private school called Integrale, Charles Rosier (https://www.icann.org/profiles/charles-rosier) spent two long years in class to prepare for ESCP Europe. In 1996, Charles Rosier started his profession at Lehman Brothers before joining UBS Warburg Investment Bank. A while later he joined Goldman Sachs Bank where he managed the finance department. His investment banking profession took him to different positions in the industry.

Charles Rosier has played a vital role in promoting environmental consciousness and has helped poor countries in developing energy and power sectors. Innoveox is a French company working with the purpose of establishing a friendly and pollution-free environment... with him being its partner. Charles Rosier supported Luci MPOWERD, a clean and renewable power solution-provider. He helped the company to build solutions that are more innovative. MPOWERD created economical LED lanterns for poor countries to permit them to have energy solutions in a cost-effective manner.

Culture Promoting Projects

At the Venice film festival, a fantastic film supported by Charles Rosier and directed by a great Italian screenwriter, won a Silver Lion award. To express his love for culture and music, he extended his support to a French female singer. He played a great part in a Silver Lion-winning film in 2006 and he helped a French musician in producing her debut album in 2012. Charles Rosier is active in different philanthropic and cultural activities. This explains the support he gave for a famous French performer and a great Silver Lion-winning movie.

Charles Rosier earned his first scientific Baccalaureate degree (which is equal to A-levels in the UK). He received his degree from ESCP Europe, which opened the path to his initial job. To get more training and to prepare for further French education, Charles Rosier studied for another two years.

Healthcare Projects of Charles Rosier

The Mapreg Drug project was Charles Rosier’s first healthcare project. He started out a healthcare project as an investor at Mapreg, a pharmaceutical company headed by Professor Etienne Baulieu. The investment by Charles Rosier allowed them to do research and, because of that, Charles Rosier was given a specific profit-share. He helped Baulieu and his colleagues to generate a new drug by funding the research.